文献速递肝病

成人急性肝衰竭患者低血清铁调素与短期生存率降低相关

Low Serum Hepcidin Is Associated With Reduced Short-Term Survival in Adults With Acute Liver Failure.
PubMed 文献 · Hepatology · 2019-03-15

该多中心队列研究分析了121例成人急性肝衰竭(ALF)患者(其中66例为对乙酰氨基酚相关)的基线铁代谢指标,发现自发性存活者较死亡/移植者铁调素水平更高、铁调素/铁蛋白比值更高,含铁调素的模型预后判别能力与已有ALF研究组指数相似。

要点

  • ALF患者及对乙酰氨基酚处理小鼠均表现为铁蛋白升高、血清铁调素及铁调素/铁蛋白比值降低。
  • 自发性存活者铁调素8.2 ng/mL高于死亡/移植者2.7 ng/mL(P < 0.001)。
  • 含铁调素的对数转换模型C统计量为0.87,与ALF研究组指数0.85相似,优于终末期肝病模型评分0.76。

核心结论

  • 成人ALF患者多种血清铁参数与3周结局显著相关,铁调素在实验性对乙酰氨基酚诱导ALF早期即下降,为独立预测因素,可能成为未来预后评分的组成部分。

研究设计与样本

  • 多中心队列研究,纳入121例成人ALF患者(其中66例为对乙酰氨基酚相关),并采用对乙酰氨基酚诱导ALF小鼠模型(于注射300 mg/kg对乙酰氨基酚前及后4小时、18小时评估)。

主要发现

  • ALF患者及对乙酰氨基酚处理小鼠均显示铁蛋白升高、血清铁调素及铁调素/铁蛋白比值降低。
  • 自发性存活者铁为29.1% vs. 死亡/移植者34.5 µmol/L(P < 0.05),转铁蛋白饱和度为60.9% vs. 79.1%(P < 0.01),自发性存活者均更低。
  • 自发性存活者铁调素为8.2 vs. 死亡/移植者2.7 ng/mL(P < 0.001),铁调素/铁蛋白比值为0.0047 vs. 0.0009(P < 0.001),自发性存活者均更高。
  • 多因素分析中含对数转换铁调素的模型C统计量为0.87,与已建立的急性肝衰竭研究组指数0.85相似,优于终末期肝病模型评分0.76。
  • 小鼠中铁调素水平与肝损伤替代指标呈负相关。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The liver has an important role in iron homeostasis through the synthesis of the serum transporter transferrin and the iron hormone hepcidin. The aim of this study was to analyze parameters of iron metabolism in a multicenter cohort of adult patients with acute liver failure (ALF) and in an acetaminophen (APAP)-induced ALF mouse model. A representative subset of 121 adults with ALF (including 66 APAP-related patients) had baseline serum samples tested for ferritin, transferrin, iron, and hepcidin. Outcomes at 3 weeks after enrollment were categorized as spontaneous survivor (SS) versus death/transplantation (NSS). Mice were assessed before (controls) and 4 and 18 hours after injection of 300 mg/kg APAP. Patients with ALF as well as APAP-treated mice displayed increased ferritin and diminished serum hepcidin and hepcidin/ferritin ratio. SS had lower iron (29.1% vs. 34.5 µmol/L; P < 0.05) and transferrin saturation (60.9% vs. 79.1%; P < 0.01), but higher hepcidin levels (8.2 vs. 2.7 ng/mL; P < 0.001) and hepcidin/ferritin ratio (0.0047 vs. 0.0009; P < 0.001) than NSS. In a multivariate analysis, a log-transformed hepcidin-containing model displayed similar prognostic power as the established Acute Liver Failure Study Group index (C-statistic 0.87 vs. 0.85) and was better than Model for End-Stage Liver Disease score (C-statistic 0.76). In mice, hepcidin levels inversely correlated with the surrogate of liver injury. Conclusion: Our findings demonstrate that several serum iron parameters significantly associate with 3-week outcomes in adults with ALF. Among them, hepcidin decreases early during experimental APAP-induced ALF, is an independent predictor and might be a useful component of future prognostic scores.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Spivak I, Arora J, Meinzer C, et al. Low Serum Hepcidin Is Associated With Reduced Short-Term Survival in Adults With Acute Liver Failure. Hepatology. 2019. PMID: 30582749. doi:10.1002/hep.30486

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。